ASTH
Income statement / Annual
Last year (2024), Astrana Health, Inc.'s total revenue was $2.03 B,
an increase of 46.72% from the previous year.
In 2024, Astrana Health, Inc.'s net income was $43.15 M.
See Astrana Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
03/31/2016 |
| Operating Revenue |
$2.03 B |
$1.39 B |
$1.14 B |
$773.92 M |
$370.25 M |
$560.62 M |
$519.91 M |
$357.75 M |
$44.05 M |
| Cost of Revenue |
$0.00
|
$1.17 B
|
$944.69 M
|
$596.14 M
|
$348.54 M
|
$486.09 M
|
$380.44 M
|
$293.73 M
|
$34.35 M
|
| Gross Profit |
$2.03 B
|
$214.96 M
|
$199.48 M
|
$177.77 M
|
$21.71 M
|
$74.53 M
|
$139.47 M
|
$64.02 M
|
$9.70 M
|
| Gross Profit Ratio |
1
|
0.16
|
0.17
|
0.23
|
0.06
|
0.13
|
0.27
|
0.18
|
0.22
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$154.11 M
|
$112.60 M
|
$77.67 M
|
$62.08 M
|
$15.59 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$154.11 M
|
$112.60 M
|
$77.67 M
|
$62.08 M
|
$15.59 M
|
$40.12 M
|
$47.24 M
|
$26.44 M
|
$16.28 M
|
| Other Expenses |
$0.00
|
$17.75 M
|
$3.94 M
|
-$3.75 M
|
$7.69 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$154.11 M
|
$130.35 M
|
$95.21 M
|
$79.59 M
|
$15.62 M
|
$40.12 M
|
$47.24 M
|
$26.44 M
|
$16.28 M
|
| Cost And Expenses |
$1.95 B
|
$1.30 B
|
$1.04 B
|
$675.74 M
|
$364.16 M
|
$526.20 M
|
$427.68 M
|
$320.17 M
|
$50.63 M
|
| Interest Income |
$14.51 M
|
$14.21 M
|
$1.98 M
|
$1.57 M
|
$405,000.00
|
$2.02 M
|
$1.26 M
|
$1.02 M
|
$0.00
|
| Interest Expense |
-$33.10 M
|
$16.10 M
|
$7.92 M
|
$5.39 M
|
$2.53 M
|
$4.73 M
|
$560,515.00
|
$79,689.00
|
$542,296.00
|
| Depreciation & Amortization |
$27.93 M
|
$17.75 M
|
$17.54 M
|
$17.52 M
|
$18.35 M
|
$18.28 M
|
$19.30 M
|
$19.08 M
|
$351,396.00
|
| EBITDA |
$68.87 M |
$123.69 M |
$112.08 M |
$100.66 M |
$206.28 M |
$48.85 M |
$102.49 M |
$68.87 M |
-$7.35 M |
| EBITDA Ratio |
0.03
|
0.09
|
0.12
|
0.14
|
0.11
|
0.09
|
0.21
|
0.16
|
-0.14
|
| Operating Income Ratio |
0.04
|
0.06
|
0.09
|
0.13
|
0.02
|
0.06
|
0.18
|
0.11
|
-0.15
|
| Total Other Income/Expenses Net |
-$8.53 M
|
$5.23 M
|
-$17.65 M
|
-$20.43 M
|
$2.78 M
|
-$6.58 M
|
-$5.80 M
|
$12.13 M
|
-$1.66 M
|
| Income Before Tax |
$80.82 M
|
$89.84 M
|
$86.62 M
|
$77.75 M
|
$8.87 M
|
$25.84 M
|
$82.63 M
|
$49.71 M
|
-$8.24 M
|
| Income Before Tax Ratio |
0.04
|
0.06
|
0.08
|
0.1
|
0.02
|
0.05
|
0.16
|
0.14
|
-0.19
|
| Income Tax Expense |
$30.89 M
|
$31.99 M
|
$40.88 M
|
$31.69 M
|
$9.18 M
|
$8.17 M
|
$22.36 M
|
$3.89 M
|
-$71,037.00
|
| Net Income |
$43.15 M
|
$60.72 M
|
$45.17 M
|
$68.92 M
|
-$23.75 M
|
$14.12 M
|
$10.84 M
|
$25.80 M
|
-$9.34 M
|
| Net Income Ratio |
0.02
|
0.04
|
0.04
|
0.09
|
-0.06
|
0.03
|
0.02
|
0.07
|
-0.21
|
| EPS |
0.9 |
1.3 |
1 |
1.57 |
-0.65 |
0.41 |
0.33 |
1.01 |
-1.79 |
| EPS Diluted |
0.89 |
1.29 |
0.99 |
1.52 |
-0.63 |
0.39 |
0.29 |
0.9 |
-1.79 |
| Weighted Average Shares Out |
$47.69 M
|
$46.71 M
|
$44.97 M
|
$43.83 M
|
$36.53 M
|
$34.71 M
|
$32.89 M
|
$25.53 M
|
$5.21 M
|
| Weighted Average Shares Out Diluted |
$48.22 M
|
$47.07 M
|
$45.60 M
|
$45.40 M
|
$37.45 M
|
$36.40 M
|
$37.91 M
|
$28.66 M
|
$5.21 M
|
| Link |
|
|
|
|
|
|
|
|
|
